Sandoz, Inc. recalled 1,680 bottles of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension on August 13, 2025. The recall stems from temperature abuse that may compromise the product's efficacy. Consumers should stop using the product immediately and contact their healthcare provider or Sandoz for guidance.
Temperature Abuse
Consumers and healthcare providers should stop using this product immediately. Contact Sandoz Inc or your healthcare provider for guidance. Notification method: Letter
The recalled product is Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, Rx only, manufactured by Novartis Manufacturing NV in Belgium. It has the NDC# 0781-6186-67 and was distributed to one consignee in California.
The recall is due to temperature abuse, which can affect the stability and effectiveness of the medication. This presents a high hazard level as improper storage conditions can lead to insufficient treatment.
No specific incidents of injury or adverse effects have been reported related to this recall. However, the potential for compromised treatment is a significant concern.
Stop using the product immediately. Contact Sandoz, Inc. or your healthcare provider for further guidance. Notification will occur via letter.
For more information, contact Sandoz, Inc. at their customer service number or visit their official website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.